The Tandem t:slim™ Mobile app is now available in New Zealand, giving users the freedom to manage their diabetes more easily by bolusing directly from their smartphones.*,‡ By seamlessly connecting to the t:slim X2™ insulin pump with Control-IQ™ technology, the app makes bolusing discreet and effortless—without the need to interact with the pump.
The app also keeps users informed by displaying vital pump data, including insulin on board, glucose levels, and time in range. Users can also receive important pump notifications, such as alerts and alarms, straight to their smartphone‡. With automatic uploads to the new cloud-based Tandem Source platform§, managing and reviewing diabetes data has never been easier or more centralised.
The t:slim X2 insulin pump with Control-IQ technology is powered by the Dexcom G7|| Continuous Glucose Monitor (CGM), providing real-time, highly accurate ^,1 glucose readings. The Dexcom G7 also eliminates the need for fingerpricks†. 97% of people using the t:slim X2 with Control-IQ technology found it easy to use2.
To learn more about the Tandem t:slim Mobile app and how it can help enhance your diabetes management, find out more here or speak to your healthcare provider.
Always read the label and use only as directed. Read the warnings available on dexcom.com/downloadsandguides and nzmsdiabetes.co.nz/resources before purchasing. Consult your healthcare professional to see if this product is right for you.
Dexcom G7 is a continuous glucose monitoring system indicated for persons with diabetes mellitus age 2 years and older where self-monitoring of blood glucose (SMBG) is indicated. Control-IQ provides continuous delivery of insulin through a subcutaneously applied infusion set. The algorithm will adjust insulin delivery according to the predicted glucose when used with a compatible CGM. The Tandem t:slim Mobile App is an accessory intended for use as a connected software device that is able to reliably and securely communicate with compatible insulin pumps. Tandem Source is a web application intended to support diabetes management through the display and analysis of information uploaded from Tandem insulin pumps.
*Bolus delivery from the Tandem t:slim mobile app requires a compatible smartphone model and operating system, software version 7.8.1 onwards on the t:slim X2 insulin pump and additional training. †If your glucose alerts and readings from the device do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. ‡Smart device sold separately. To view a list of compatible devices, visit tandemdiabetes.com/products/software-apps/device-compatibility. §Uploads to the Tandem Source platform do not take place in real- time and should not be relied upon by healthcare providers, pump users, or caregivers for remote patient monitoring. ||Dexcom G7 CGM sold separately. ^Compared to previous generations of Dexcom systems
1. Welsh JB, et al. Comparisons of Fifth-, Sixth-, and Seventh-Generation Continuous Glucose Monitoring Systems. J Diabetes Sci Technol. 2024;18(1):143-7. 2. Data on File.
© 2025 Tandem Diabetes Care, Inc. All rights reserved. Tandem Diabetes Care, Control-IQ, t:slim X2 and t:slim are registered trademarks or trademarks of Tandem Diabetes Care, Inc
Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom G6, Dexcom G7, Dexcom ONE+, Dexcom Share, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. © 2025 Dexcom, Inc. All rights reserved. New Zealand Medical and Scientific Limited is a Dexcom company: 2A Fisher Crescent, Mount Wellington, Auckland 1060.
MAT-7974
The Tandem t:slim™ Mobile app is now available in New Zealand, giving users the freedom to manage their diabetes more easily by bolusing directly from their smartphones.*,‡
Now you can get all the latest news and updates of our products, events and resources right into your inbox.
